SANOFI PASTEUR SA Patent applications |
Patent application number | Title | Published |
20160045535 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 - The invention especially relates to multivalent vaccine compositions that can treat or prevent at least 60, preferably 75% of infections caused by | 02-18-2016 |
20150216963 | Method for Purifying the Rabies Virus - The subject of the invention is a method for purifying the rabies virus, comprising a single ion-exchange chromatography step, said step being cation exchange chromatography according to which:
| 08-06-2015 |
20140373383 | ROTARY DRUM FOR USE IN A VACUUM FREEZE-DRYER - A rotary drum ( | 12-25-2014 |
20140220073 | Immunization Compositions and Methods - The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus. | 08-07-2014 |
20140154329 | Process For Stabilizing An Adjuvant Containing Vaccine Composition - The present invention relates to a process for stabilizing an adjuvant containing vaccine composition, an adjuvanted vaccine composition in dry form and in particular a process for stabilizing an influenza vaccine composition, particularly an adjuvanted influenza vaccine composition in dry form. | 06-05-2014 |
20140093556 | Immunological Compositions Against HIV - The disclosure relates to immunological compositions for vaccinating human beings against infection by the Human Immunodeficiency Virus (HIV). | 04-03-2014 |
20130344109 | Immunogenic Compositions - The present invention provides compositions comprising a Chlamydial major outer membrane protein (referenced herein as “MOMP”), from at least one Chlamydial serovar and an adjuvant, characterized in that the adjuvant comprises the product E6020 having CAS Number 287180-63-6. The composition may further comprise at least one carrier system (e.g., emulsion, mineral particle). The MOMP protein may be derived from any species of | 12-26-2013 |
20110306761 | Process For Preparing Prophyrin Derivatives, Such As Protoprophyrin (IX) And Synthesis Intermediates - The present invention relates to a process for preparing a porphyrin of formula (I), optionally in the form of a salt with an alkali metal and/or in the form of a metal complex: | 12-15-2011 |
20110212129 | Method for Producing the Flu Virus - The invention relates to a method for producing flu virus according to which:
| 09-01-2011 |
20110207173 | Self-Replicating Vector Lacking An Antibiotic-Resistance Gene - The subject matter of the present invention is a novel vector and the use thereof for producing a heterologous protein or a gene of interest, that can be used, for example, in the context of an immunization or gene therapy programme and concerns in particular a self-replicating vector lacking an antibiotic-resistance gene, comprising a sequence encoding the ccdA protein functionally linked to a first promoter, the sequence of the Cer locus and a heterologous sequence, functionally linked to a second promoter. | 08-25-2011 |
20110206730 | Dengue Chimeric Viruses - The invention relates to Dengue chimeric viruses which are less prone to accumulate point mutations and genetic variations. In these Dengue chimeric viruses, the NS5 gene, which encodes polymerase, has been replaced by the corresponding NS5 sequence of a Yellow Fever virus. | 08-25-2011 |
20110151506 | Process for Culturing Adherent Cells - The subject of the present invention is a process for producing adherent cells comprising:
| 06-23-2011 |
20110117123 | Multivalent Vaccine Composition With Mixed Carrier - The invention concerns a pharmaceutical composition for treating or preventing a certain number of infections caused by pathogenic agents such as bacteria, comprising as immunogen, one or several polyosides derived from one or several pathogenic agents. The polyosides are in the form of conjugates, coupled with a carrier protein. The composition contains at least two types of conjugates, each being at least characterised by a different protein carrier. | 05-19-2011 |
20110052624 | Type 5 And Type 8 Capsular Polysaccharides Of Overproducing S. Aureus Strains - The invention relates to the type 5 and type 8 capsular polysaccharides produced by overproducing | 03-03-2011 |
20100330656 | Method for the Production of Overproducing Staphylococcus Aureus Strains - The present invention relates to a method for the production of an overproducing | 12-30-2010 |
20100270202 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a protection against the 4 dengue serotypes in a patient, comprising
| 10-28-2010 |
20100239612 | Method of Immunization Against the 4 Serotypes of Dengue Fever - The invention relates to a method for inducing protection against the 4 serotypes of dengue fever in a patient, comprising:
| 09-23-2010 |
20100221285 | Method of Immunization Against the 4 Dengue Serotypes - The invention relates to a method for inducing a homologous protection against the 4 dengue serotypes in a patient, comprising the sequential administration, to said patient, (i) of a dose of a vaccinal dengue virus of a first serotype and of a dose of a vaccinal dengue virus of a second serotype, and (ii) of a dose of a vaccinal dengue virus of a third serotype and of a dose of a vaccinal dengue virus of a fourth serotype, in which the vaccinal dengue viruses (ii) are administered at least 30 days and at most 1 year after administration of the vaccinal viruses (i). | 09-02-2010 |
20100215692 | Dengue Chimeric Viruses - The invention relates to Dengue chimeric viruses which are less prone to accumulate point mutations and genetic variations. In these Dengue chimeric viruses, the NS5 gene, which encodes polymerase, has been replaced by the corresponding NS5 sequence of a Yellow Fever virus. | 08-26-2010 |
20090023197 | Method for purifying a viral suspension - The invention relates to a method for obtaining viruses from a liquid viral suspension, according to which:
| 01-22-2009 |
20090017074 | CULTURE MEDIUM FOR HAEMOPHILUS INFLUENZAE TYPE B - The invention relates to a culture medium for | 01-15-2009 |
20080242857 | Process For Preparing Porphyrin Derivatives, Such As Protoporphyrin (IX) And Synthesis Intermediates - The present invention relates to a process for preparing a porphyrin of formula (I), optionally in the form of a salt with an alkali metal and/or in the form of a metal complex: | 10-02-2008 |